Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re: Eliquis (Apixaban) Products Liability Litigation
Case Number:
1:17-md-02754
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Adams & Reese
- Alston Hunt
- Aylstock Witkin
- Bickerton Law Group
- Bilbo Law Office
- Bruno & Bruno LLP
- Burg Simpson
- Dentons
- DLA Piper
- Dugan Law Firm
- Farmer Purcell
- Jacobs & Crumplar
- Kiesel Law
- Kirtland & Packard
- Koskoff Koskoff
- Kralovec Jambois
- Law Office of Leon Aussprung
- Marc J. Bern & Partners
- Miller Weisbrod
- Napoli Shkolnik
- Rueb Stoller
- Showard Law Firm
- Stites & Harbison
- Walters Papillion
- Will Ferguson & Associates
Companies
Sectors & Industries:
-
November 29, 2017
Judge Tosses 24 New Complaints In Eliquis MDL
A New York federal judge on Wednesday tossed 24 new lawsuits filed in multidistrict litigation over claims that Pfizer Inc. and Bristol-Myers Squibb Co. didn't warn people about risks associated with the blood thinner Eliquis, finding that the claims are preempted by federal law.
-
October 13, 2017
Eliquis MDL Sees 24 Suits Trimmed Due To Forum Rule
A New York federal judge on Friday dismissed 20 suits against Pfizer Inc. and Bristol-Myers Squibb Co., wiping out the bulk of what remains of multidistrict litigation alleging that the companies didn't warn consumers of the risks associated with the blood thinner Eliquis, saying they can't be sent back to state court.
-
July 28, 2017
Only 1 Suit Left In Eliquis MDL As 20 More Cases Get Cut
Pfizer Inc. and Bristol-Myers Squibb Co. have largely beat multidistrict litigation accusing them of not properly warning about the risks tied to the blood thinner Eliquis after a New York federal judge dismissed all but one suit.